Can Psilocybin Rewire An Injured Brain? Science Challenges Treatment Norms

Conventional TBI treatments only manage symptoms, but psilocybin may actually rewire damaged brains and regenerate neural circuits that doctors thought were permanently lost.

How Slovenia’s Cannabis Law Challenges Stigma and Protects Everyday Users

Slovenia’s 2025 cannabis law shatters European norms with workplace protections and cultivation rights that challenge everything you thought possible about drug policy.

Federal Study Finds Older Cannabis Users Perform Better on Cognitive Tests Than Non-Users

Federal research reveals cannabis users aged 44-81 dramatically outperform non-users on cognitive tests, challenging decades of anti-marijuana messaging about brain health.

Growthstalk Doubles Cannabis Output to 400 Lbs Daily With $2m Expansion Bet

GrowthStalk bets $2 million on doubling cannabis capacity to 400 pounds daily, but can this massive expansion gamble actually pay off?

Alcohol Giants Brace as Trendy Cannabis Drinks Threaten Their Sales Stronghold

As cannabis beverages surge from a $1.16 billion global market in 2023 toward projections reaching as high as $117 billion by 2032, traditional alcohol companies are scrambling to defend territory they’ve dominated for centuries.

Canada’s Cannabis Market: Is It Beating the Black Market Once and for All?

Legal cannabis operators have decisively outmaneuvered black market competitors, with 69% of Canadians now purchasing exclusively through legitimate channels.

Brewing With Cannabis Seeds Boosts Beer’s Nutritional Power Without Compromising Flavor or Fermentation

Cannabis seeds transform beer into a nutritional powerhouse with complete proteins and omega fatty acids while creating surprisingly harmonious flavors that challenge brewing traditions.

Same-Day PTSD Relief? Government Study Finds Marijuana Eases Veterans’ Symptoms After Use

Should veterans and other PTSD sufferers consider cannabis as a viable therapeutic option? New government-backed research suggests the answer might be surprisingly encouraging, with some veterans reporting same-day symptom relief.

Groundbreaking Trial Shows Inhaled Cannabis Rapidly Eases Migraines

UCSD’s double-blind trial reveals inhaled cannabis slashes migraine frequency by 40% in just 15 minutes without serious side effects reported.

New Jersey’s First Cannabis Lounges Approved, A Bold Step Toward Equitable Legalization

New Jersey breaks barriers with cannabis lounges that prioritize minority ownership—but strict rules reveal the complex reality of legalized marijuana.